Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 93.70
+7.80 (9.08%)
Sep 23, 2026, 5:24 PM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 3.47 million as of September 23, 2026. Its market cap has decreased by -42.39% in one year.
Market Cap
3.47M
Enterprise Value
-4.74M
Revenue
-1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
93.70
ChartMarket Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 3.47M, a decrease of -91.40%. That is a compound annual growth rate of -34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 3.47M | -29.53% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.19B |
| BrainsWay | 1.65B |
| Rafa Laboratories | 1.60B |
| XTL Biopharmaceuticals | 23.84M |
| Erika Carmel-Tech | 20.88M |
| Can-Fite BioPharma | 14.99M |
| Bio-View | 10.04M |